Low Dose Niacin (Vitamin B3) for Parkinson's Disease (NAPS)
NAPS: Niacin for Parkinson's Disease
Sponsor: VA Office of Research and Development
Terminated
Not enough recruitment
Other terminated trials from VA Office of Research and Development
- SCI · Phase EARLY_PHASE1 · Feb 2026
- Spinal Cord Injury · Phase NA · Dec 2025
- Anxiety Disorders · Phase NA · Nov 2025
- Anemia · Phase PHASE2 · Jul 2025
- Early Stage Lung Cancer (I and II) · Phase PHASE2 · Mar 2025
See all terminations from VA Office of Research and Development
Other Parkinson's Disease trials with similar outcome
Listed as NCT03808961, this NA trial focuses on Parkinson's Disease and remains terminated or withdrawn. Sponsored by VA Office of Research and Development, it has been updated 14 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
Apr 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Apr 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Feb 2024 — Jul 2024 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Apr 2022 — Feb 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 9 earlier versions
-
May 2021 — Apr 2022 [monthly]
Recruiting NA
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Jul 2020 — Nov 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2020 — Jul 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2020 — Feb 2020 [monthly]
Not Yet Recruiting NA
-
Jun 2019 — Jan 2020 [monthly]
Not Yet Recruiting NA
-
May 2019 — Jun 2019 [monthly]
Not Yet Recruiting NA
-
Feb 2019 — May 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- VA Office of Research and Development
For direct contact, visit the study record on ClinicalTrials.gov .